Update your location to show providers, locations, and services closest to you.
Critical Care Medicine Specialist, Pulmonologist (Lung Specialist)
This study is open to adults with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs). People who have a form of PF-ILD other than Idiopathic Pulmonary Fibrosis (IPF) can join the study. If they already take nintedanib, they can continue…
This study is open to adults with a lung disease called Idiopathic Pulmonary Fibrosis (IPF). People can join the study if they are 40 years or older. If they already take nintedanib or pirfenidone for their IPF, they can continue treatment…
This randomized, double-blind, placebo matched to efzofitimod-controlled, study will evaluate the safety, tolerability, immunogenicity, pharmacokinetic (PK), and preliminary efficacy of multiple ascending doses of IV efzofitimod in participants with…
28 publications
2021
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
PubMed • Publisher's site2021
Annals of the American Thoracic Society
Publisher's site2021
ERJ Open Research
PubMed • Publisher's site2021
Advances in respiratory medicine
PubMed • Publisher's site2021
Neurology Clinical Practice
Publisher's site